Antibiotic Developments Insights
The panel combatting the rise of antibiotic resistance in UTIs
Rebekah Jordan sits down with Oliver Schacht, CEO of OpGen, to discuss the increasing prevalence of antibiotic resistance in Urinary Tract Infections (UTIs), and how OpGen’s Unyvero can quicken the AR diagnosis process.
11 Aug 2022
Antimicrobial resistance: Here we go again
Why we should pay attention to the latest antimicrobial resistance research.
17 Feb 2022
The future of combatting antimicrobial resistance
Oliver Schacht, CEO of OpGen looks at why technologies including artificial intelligence and machine learning could be key to combatting antimicrobial resistance.
29 Nov 2021
AMR in Orthopedics – Benefits of topical treatment and latest advances
Michael Harris, chief executive officer of Biocomposites explores the threat of antibiotic resistance and how antibiotics are being used within the orthopaedics industry.
7 Oct 2021
Improving our approach to fighting AMR
Oliver Schacht, CEO of precision medicine and genomics analysis company OpGen explores what we need to do to improve our fight against antimicrobial resistance (AMR).
11 Aug 2021
The state of bioinformatics in the fight against AMR
Oliver Schacht, CEO of OpGen, Inc., examines the potential of bioinformatics in helping to fight antimicrobial resistance.
27 Jan 2021
nobeastsofierce Shutterstock
Glox Therapeutics awarded grant to accelerate development of precision antibiotics
Glox Therapeutics, a company pioneering the development of precision antibiotic therapies based on naturally occurring bacteriocins, has announced it has secured £1 million in grant funding from PACE (Pathways to Antimicrobial Clinical Efficacy).
25 Nov 2024
Sawyer0/Adobe Stock
Global study shows cefiderocol’s success in treating resistant infections
Shionogi & Co., Ltd. shared new data at IDWeek 2024 from the PROVE study, the largest global real-world evidence review of Fetroja/Fetcroja (cefiderocol).
17 Oct 2024
Shutterstock
WHO Report Shows Increase in HIV Drug Resistance to Dolutegravir
The World Health Organization’s (WHO) latest HIV Drug Resistance (HIVDR) Report tells us where drug resistance is growing and offers recommendations for countries to monitor and respond to the potential challenges.
8 Mar 2024
Tjoapack Launches Innovative Customer Dashboard to Drive Pharma Supply Chain Collaboration
New digital platform transforms transparency, workflow efficiency, and client communication in real time
Valneva Scotland
Investing today for the leaders of tomorrow
Scotland’s life sciences sector is a crucial part of the nation’s economy, contributing innovation in areas such as biotechnology, pharmaceuticals, and vaccine manufacture. Jeanette Rigby, director human resources at Valneva Scotland, discusses.
12 May 2025
Ajax9 Shutterstock
Top reasons to rent product inspection systems
For manufacturers facing production challenges, renting product inspection systems can be a cost-effective, flexible solution. Christine Gottschalk, head of PI Test and Demo Center at Mettler-Toledo, discusses the benefits of rental technologies.
8 May 2025
Vitalii Vodolazskyi Shutterstock
Is pharma ready for the next supply chain test?
Niklas Adamsson, chief operating officer at Envirotainer discusses why pharma must look beyond its own walls to strengthen supply chain resilience.
2 May 2025
Pharmaceutical Insights + Pharmaceutical Logistics & Distribution Insights
Hadrian Shutterstock
EU GMP Annex 1: Tackling compliance with confidence
August 2025 marks two years since revisions to Annex 1 of the European Union’s Good Manufacturing Practice (GMP) guidelines were introduced. Niamh Bissett, director, business transformation at West Pharmaceutical Services discusses.
1 May 2025
Maks_lab Shutterstock
Q&A: Is the key to personalised medicine programmability?
Sail Biomedicines’ Kerry Benenato and Rajesh Ramaswamy discuss the roles artificial intelligence (AI) can play in informing programmability, using the example of Sail’s tailored Endless RNATM (eRNATM) medicines.
30 Apr 2025
Drozd Irina Shutterstock
Ask the Expert: The role of analytical services in drug development
Ramesh Jagadeesan, vice president, head of analytical services at Recipharm shares his insights on the role of analytical services in drug development.
29 Apr 2025
Sponsored Content
Stevanato Group
A one-stop shop for even the most challenging Monoclonal Antibodies (mAbs)
The biologics market is expanding rapidly – with a compound annual growth rate of 15% predicted until 2027. But this new generation of drugs comes with unique challenges that require an innovative approach underpinned by extensive experience.
12 Mar 2025
08:00
Tjoapack Launches Innovative Customer Dashboard to Drive Pharma Supply Chain Collaboration
New digital platform transforms transparency, workflow efficiency, and client communication in real time
Sponsored Content
Stevanato Group
A one-stop shop for even the most challenging Monoclonal Antibodies (mAbs)
The biologics market is expanding rapidly – with a compound annual growth rate of 15% predicted until 2027. But this new generation of drugs comes with unique challenges that require an innovative approach underpinned by extensive experience.
12 Mar 2025
08:00